Andreas Gerber
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 0.5%
- Antibiotics Pharmacokinetics and Efficacy
Papers in ⓘ
-
- Antibiotic Resistance in Bacteria 15
- Pharmacology 21
- Antibiotics Pharmacokinetics and Efficacy 19
- Co-authors
- William A. Craig (7 shared papers)Matthias Klusch (13 shared papers)P Weidmann (12 shared papers)David L. Cohn (1 shared paper)Marcus Schmidt (1 shared paper)Karl W. Lauterbach (20 shared papers)Markus Lüngen (17 shared papers)Charalabos‐Markos Dintsios (8 shared papers)
- Journals
- The Journal of Infectious Diseases (4 papers)Journal of Antimicrobial Chemotherapy (4 papers)Clinical Infectious Diseases (3 papers)Drugs (3 papers)Hypertension (3 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Andreas Gerber
104 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 180
- Molecular Medicine 578
- Pharmacology 924
- Applied Microbiology and Biotechnology 99
- Clinical Biochemistry 211
- General Health Professions 369
Countries citing papers authored by Andreas Gerber
This map shows the geographic impact of Andreas Gerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Gerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Gerber more than expected).
Fields of papers citing papers by Andreas Gerber
This network shows the impact of papers produced by Andreas Gerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Gerber. The network helps show where Andreas Gerber may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Gerber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1981 | 278 | |
| 2 | Semantic Web Service Composition Planning with OWLS-Xplan ∗ | 2005 | 174 |
| 3 | 1985 | 146 | |
| 4 | 2011 | 130 | |
| 5 | 2008 | 123 | |
| 6 | 1983 | 122 | |
| 7 | 1983 | 112 | |
| 8 | 2002 | 105 | |
| 9 | 1986 | 98 | |
| 10 | 1982 | 89 | |
| 11 | 2010 | 88 | |
| 12 | 1981 | 58 | |
| 13 | 1982 | 54 | |
| 14 | 1991 | 51 | |
| 15 | 2012 | 48 | |
| 16 | 2012 | 46 | |
| 17 | 1983 | 44 | |
| 18 | 1984 | 43 | |
| 19 | 1981 | 43 | |
| 20 | Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa: characterization and virulence in normal and leukopenic mice. | 1982 | 41 |
About Andreas Gerber
Andreas Gerber is a scholar working on Molecular Medicine, Pharmacology, Applied Microbiology and Biotechnology, General Health Professions and Management Science and Operations Research, having authored 112 papers that have together received 2.9k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (19 papers), Health and Medical Studies (15 papers), Antibiotic Resistance in Bacteria (15 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers), Pharmaceutical studies and practices (6 papers), Business Process Modeling and Analysis (6 papers), Auction Theory and Applications (6 papers) and Social and Demographic Issues in Germany (5 papers). The work is most often cited by research in Molecular Medicine (578 citations), Pharmacology (924 citations), Applied Microbiology and Biotechnology (99 citations), Clinical Biochemistry (211 citations) and General Health Professions (369 citations). Andreas Gerber has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include William A. Craig, Matthias Klusch, P Weidmann, David L. Cohn, Marcus Schmidt, Karl W. Lauterbach, Markus Lüngen, Charalabos‐Markos Dintsios, Dominik E. Uehlinger and A. Paul Vastola. Their work appears in journals such as The Journal of Infectious Diseases, Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases, Drugs and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.